Type 1 diabetes, COVID-19 vaccines and short-term safety: Subgroup analysis from the global COVAD study.

Tulika Chatterjee Naveen RNarmadha NairAbraham Edgar Gracia-Ramos Bhupen Barman Parikshit Sen Masataka Kuwana Sreoshy Saha Albert Selva-O'Callaghan Arun Kumar R Pande Tsvetelina V Velikova Ioannis Parodis Ai Lyn Tan Samuel Katsuyuki ShinjoHiya BoroVikas Agarwal Rohit Aggarwal Latika Guptanull null

Published in: Journal of diabetes investigation (2023)

COVID-19 vaccination was safe and well tolerated in patients with type 1 diabetes with similar AE profiles compared with HCs, although severe rashes were more common in type 1 diabetes patients.

Keyphrases

type diabetes
coronavirus disease
sars cov
end stage renal disease
ejection fraction
chronic kidney disease
glycemic control
cardiovascular disease
insulin resistance
prognostic factors
randomized controlled trial
adipose tissue
skeletal muscle
drug induced